Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Conversation today with Kelly Williams of Alliacense

I actually don't see a problem here. I've been following this stock for a few years and I only recall 2 or 3 occasions when the SP significantly rose before news was announced.

Also, If I new for a fact that "a" license was going to be announced on Friday and I had cash to invest, I sure as h*ll would not invest based on this stock's past performance after license announcements.

I think the Alliance rep was trying to put the shareholder's mind at ease by stating - "yes we're still alive here - we will get more licenses and who knows, you may even see one on Friday". I personally don't think the Alliance Rep actually knows if there will be a license announcement on Friday.

I think the pop on the SP yesterday was due to the fact that we're getting closer to the date of an officially recertified 336 - or there is something postive in the works that got leaked. My point is - I don't think the positive news has anything to do with a new license. (I certainly wouldn't buy 400K shares because of an upcoming license announcement. )

Sorry to ramble - JMOs.

Share
New Message
Please login to post a reply